NCT06688721

Brief Summary

The goal of this pragamatic trial is to assess the impact of eco-driving assistance (EDA) system on professional bus drivers' health and well-being. The main questions it aims to answer are:

  • Does the eco-driving assistance (EDA) act as a stressor for bus drivers ?
  • Does the physiological and psychological perceived stress increase when bus drivers are driving bus equipped with eco-driving assistance (EDA) ? An additional question consists in assessing the association between stress measurements and biomarkers in biological samples. Researchers will compare the heart rate variability (HRV) and perceived stress level when participant are allocated to EDA-equipped buses and non-EDA-equipped buses Participants will:
  • Drive buses equipped with eco-driving assistance (EDA)
  • Drive buses without eco-driving assistance (EDA)
  • Wear a wearable electrocardiogram (ECG) device (Bittium Faros) to record the heart rate variability (HRV)
  • Answer a questionnaire at the end of each working day (end-of-service questionnaire)
  • When allocated to bus with eco-driving assistance (EDA), read the EDA-generated report and answer some related questions in the end-of-service questionnaire
  • Upon acceptance only, a collection of biological samples and physiological measurement will be performed

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 1, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 14, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

February 10, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

March 13, 2025

Status Verified

March 1, 2025

Enrollment Period

6 months

First QC Date

November 1, 2024

Last Update Submit

March 10, 2025

Conditions

Keywords

Public transportEco-driving assistanceOccupational healthHealth and well-beingBus drivers

Outcome Measures

Primary Outcomes (1)

  • Heart rate variability (HRV)

    Heart rate variability (HRV) will be measured using the Bittium Faros ECG device. Participants will continuously wear the device throughout their working day and during one full non-working night, to obtain baseline value.

    From enrollment in the study to at least 5 days and until the endpoint is reached (i.e. at least 5 hours driving shifts with buses equipped with EDA and 5 hours driving shifts with buses without EDA) but for a maximum duration of 14 days

Secondary Outcomes (5)

  • Perceived stress

    1 day at the beginning of the study, once the eligibility has been confirmed

  • Perceived stress

    From enrollment in the study to at least 5 days and until the endpoint is reached (i.e. at least 5 hours driving shifts with buses equipped with EDA and 5 hours driving shifts with buses without EDA) but for a maximum duration of 14 days

  • Perceived stress

    From enrollment in the study to at least 5 days and until the endpoint is reached (i.e. at least 5 hours driving shifts with buses equipped with EDA and 5 hours driving shifts with buses without EDA) but for a maximum duration of 14 days

  • Stress biomarkers in saliva samples

    From enrollment in the study to at least 5 days and until the endpoint is reached (i.e. at least 5 hours driving shifts with buses equipped with EDA and 5 hours driving shifts with buses without EDA) but for a maximum duration of 14 days

  • Perceived stress linked with eco-driving assistance system generated report

    From enrollment in the study to at least 5 days and until the endpoint is reached but for a maximum duration of 14 days and only when allocated to the intervention

Study Arms (2)

EDA

EXPERIMENTAL

Driving shifts with EDA-equipped buses

Device: Driving a bus equipped with EDA

Control

NO INTERVENTION

Driving shifts with non-EDA-equipped buses

Interventions

Eco-driving assistance (EDA) systems is a technology integrated into vehicles that helps drivers to optimize fuel efficiency and reduce emissions by providing real-time feedback and guidance on driving behaviors. The system typically analyzes several driving behaviours that are measured using different captors and sensors. These systems aim to reduce the overall carbon footprint of driving, leading to cost savings for the public transport company and reduced environmental impact.

EDA

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult active bus driver
  • having signed the informed consent
  • having worked for at least one year as TPF bus driver
  • working at least 30 hours a week
  • no planned extended absences in the next 6 months (civil service, military service, long- term leave, retirement)

You may not qualify if:

  • wearing a medical active implant (pacemaker, cardiac defibrillator, neurostimulator, other electronic implant)
  • known allergy or skin sensitivity to plasters

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

TPF

Givisiez, Canton of Fribourg, 1762, Switzerland

RECRUITING

Related Publications (1)

  • Krummenacher M, Ghosh M, Turner MC, Guseva Canu I. Protocol for a pseudo-randomized controlled trial to assess the impact of eco-driving assistance systems on bus drivers' stress responses. Environ Health Prev Med. 2025;30:90. doi: 10.1265/ehpm.25-00259.

Study Officials

  • Irina Guseva Canu, Professor

    Unisanté

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Irina Guseva Canu, Professor

CONTACT

Maryline Krummenacher, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: Within subject design Each participant will be allocated to both the intervention (i.e. driving shifts with EDA-equipped buses) and the control (i.e. driving shifts with non-EDA-equipped buses) conditions
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2024

First Posted

November 14, 2024

Study Start

February 10, 2025

Primary Completion

August 1, 2025

Study Completion

August 1, 2025

Last Updated

March 13, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

All data generated during this study will be shared with restrictive access. Data are considered as coded as long as the identity of the participants involved is preserved.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
IPD will be available at the end of the project, once all the data have been collected
Access Criteria
IPD and supporting information (containing only coded data) will be stored on the secured institutional data repository (Unisanté repository). Access will be given upon request to the principal investigator.
More information

Locations